⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NTRA News
Natera, Inc. Common Stock
Precision Diagnostics Research Report 2026 - Global $30+ Bn Market Trends, Opportunities, and Forecasts to 2031
globenewswire.com
EXAS
NTRA
LH
Prospera™ Featured in Landmark Interventional Study Advancing Lung Transplant Care
businesswire.com
NTRA
Natera Publishes Clinical Validation of Latitude™ Tissue-Free MRD Test in Colorectal Cancer
businesswire.com
NTRA
Natera’s Fetal Focus™ Single Gene NIPT (sgNIPT) Selected for Prestigious Oral Plenary Presentation at Society of Maternal Fetal Medicine (SMFM) Meeting
businesswire.com
NTRA
Liberty All-Star® Growth Fund, Inc. December 2025 Monthly Update
businesswire.com
ASG
NVDA
AAPL
MSFT
GOOGL
AMZN
META
OLLI
NTRA
LLY
CW
SMTC
ACAD
IDXX
ROST
CRM
BAH
CYBR
SPOT
SPSC
TTC
TDG
Peptide Therapeutics Market Report 2025-2035: Industry to Experience Robust Growth with a CAGR of 6.8% Through 2035 - Subcutaneous Route to Command Over 65% Share - ResearchAndMarkets.com
businesswire.com
APLS
BLRX
LLY
NTRA
NVO
PLTK
ZBRA
Genomic Testing Market Projected to Reach US$ 41.34 Billion by 2035, Supported by Rising Clinical Oncology Testing Volumes | Astute Analytica
globenewswire.com
NTRA
GH
EXAS
ILMN
PACB
TXG
TMO
TWST
Natera Announces Next Breakthrough in MRD-Based Risk Stratification, Leveraging Multi-Modal AI Modeling
businesswire.com
NTRA
Natera to Scale AI Foundation Models in Precision Medicine with NVIDIA
businesswire.com
NTRA
NVDA
Natera Announces Strong Preliminary Fourth Quarter and 2025 Financial Results Driven by Record Signatera™ Growth
businesswire.com
NTRA